Related Experiment Video
Updated: Mar 31, 2026
10:56
A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
8.6K
Familial hypercholesterolemia: clues to catching it early
1Johns Hopkins University School of Medicine, Baltimore, MD, USA.?Email: richardsafeer@gmail.com.
The Journal of Family Practice
|October 21, 2015
Summary
Learn to identify critical red flags in patients that indicate high risk. Early detection and intervention can significantly improve patient survival rates and quality of life.
Area of Science:
- Clinical Medicine
- Patient Risk Assessment
Background:
- Identifying patients at risk is crucial for timely intervention.
- Proactive healthcare strategies can improve patient outcomes.
Purpose of the Study:
- To outline key indicators for patient risk.
- To provide actionable steps for healthcare providers to potentially extend patient life.
Main Methods:
- Review of clinical indicators associated with patient risk.
- Development of a guideline for risk assessment and intervention.
Main Results:
- Specific red flags identified that correlate with increased patient risk.
- Evidence-based strategies proposed to mitigate risks and improve prognosis.
Conclusions:
- Recognizing patient red flags enables early intervention.
- Implementing identified strategies can lead to improved patient survival and longevity.
Related Concept Videos
01:29Cholesterol: Significance and Regulation
1.9K
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
1.9K
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
750
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
750
01:29Pharmacogenomics: Identification of New Drug Targets
84
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
84
01:26Coronary Artery Disease IV: Preventive Measures
851
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
851
01:26Atherosclerosis III: Management
582
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
582
01:30Atherosclerosis I: Introduction
2.0K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.0K